Pancreatic intraductal papillary mucinous neoplasms: Current diagnosis and management

Table 3 Management of intraductal papillary mucinous neoplasm patients regarding indications for surgery according to the International, European and American Gastroenterological Association guidelines[5,8,13,20-22,41]

Guidelines	Management
IAP (2006)	Indications: Surgery
AGA (2015)	Indications: Surgery
IAP (2017)	High risk stigmata: Surgery
	Worrisome features: Surgery versus close surveillance based on: Patients’ age/comorbidities: More aggressive management (surgery) in young patients
	EUS findings: Surgery indicated in clear MPD involvement and/or high-risk features
European (2018)	Absolute indications: Surgery
	Relative indications: Surgery according to criteria count, depending on comorbidities
	In fit patients: surgery for 1 criterion
	In patients with significant comorbidities: surgery for 2 criteria

IAP: International Association of Pancreatology; AGA: American Gastroenterological Association; EUS: Endoscopic ultrasonography; MPD: Main pancreatic duct.